Janssen Robert 4
4 · DYNAVAX TECHNOLOGIES CORP · Filed Feb 20, 2025
Insider Transaction Report
Form 4
Janssen Robert
Chief Medical Officer and VP
Transactions
- Tax Payment
Common Stock
2025-02-18$12.93/sh−4,041$52,250→ 77,485 total - Exercise/Conversion
Restricted Stock Unit
2025-02-18−11,904→ 23,806 total→ Common Stock (11,904 underlying) - Exercise/Conversion
Common Stock
2025-02-18+11,904→ 81,526 total
Footnotes (2)
- [F1]Each RSU represents a contingent right to receive one share of common stock. The RSUs vest over three years with 1/3 vesting on each annual anniversary of February 15, 2024.
- [F2]Shares withheld by Dynavax Technologies Corporation to satisfy tax withholding requirements on vesting of restricted stock units.